Synthes Settles New Jersey Inquiry
Synthes, maker of the ProDisc artificial spinal disk, has settled an inquiry by the New Jersey attorney general, which accused the device maker of failing to disclose financial conflicts of interest for doctors researching its products, according to a report by the New York Times.
The attorney general claims that the physicians who were testing the ProDisc were, in many cases, recommending its use to patients, and nearly half of those testing the product were being compensated with company stock for doing so.
Synthes has agreed to disclose any future payments or investments held by doctors involved in researching its products through its Web site and will pay $236,000 to reimburse the attorney general's office for its investigation.
Read the New York Times' report on the Synthes settlement.
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
Latest Articles
- 10 Factors Integral to Developing an Employee Compensation Plan
- ASC Industry Leader to Know: Senior Vice President of Access MediQuip Greg Lueck
- National Medical Billing Services Founder Lisa Rock Speaks on Optimizing Managed Care Contracts
- Houston Surgery Center Now Offers Cleft Lip & Palate Surgical Treatment
- 12 Hospitals Awarded for Eliminating Healthcare-Associated Infections
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,460.65 Trade time:3:34PM EDT Value change:▼42.16 (-0.34%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,841.76 Trade time:3:34PM EDT Value change:▲2.68 (0.09%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,314.90 Trade time:3:34PM EDT Value change:▼1.73 (-0.13%)Channels
